• OPEN AN ACCOUNT
Indian Indices
Sensex
76,391.39 -363.66
( -0.47%)
Global Indices
Nasdaq
52,250.80 5.16
(0.01%)
Dow Jones
7,521.33 -8.87
(-0.12%)
Hang Seng
66,278.94 163.34
(0.25%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.31 -0.12
(-0.13%)
EUR-INR
109.90 -0.27
(-0.25%)
GBP-INR
129.11 -0.56
(-0.43%)
JPY-INR
0.59 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
45.9
43218.36
EPS(TTM)
Face Value()
Div & Yield %
75.36
2
0.81
 

Ajanta Soya reports standalone net loss of Rs 1.19 crore in the March 2026 quarter
Jun 01,2026
Net loss of Ajanta Soya reported to Rs 1.19 crore in the quarter ended March 2026 as against net profit of Rs 5.02 crore during the previous quarter ended March 2025. Sales declined 13.25% to Rs 336.92 crore in the quarter ended March 2026 as against Rs 388.39 crore during the previous quarter ended March 2025.

For the full year,net profit declined 69.13% to Rs 8.38 crore in the year ended March 2026 as against Rs 27.15 crore during the previous year ended March 2025. Sales declined 1.66% to Rs 1307.67 crore in the year ended March 2026 as against Rs 1329.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales336.92388.39 -13 1307.671329.81 -2
OPM %0.301.57 -0.932.57 -
PBDT-0.157.36 PL 15.1939.17 -61
PBT-1.006.60 PL 12.0836.32 -67
NP-1.195.02 PL 8.3827.15 -69